"10.1371_journal.pone.0151511","plos one","2016-03-15T00:00:00Z","Chikara Komiya; Kyoichiro Tsuchiya; Kumiko Shiba; Yasutaka Miyachi; Shunsaku Furuke; Noriko Shimazu; Shinobu Yamaguchi; Kazuo Kanno; Yoshihiro Ogawa","Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan; Kanno Clinic, Tokyo, Japan; Japan Agency for Medical Research and Development, CREST, Tokyo, Japan","Conceived and designed the experiments: CK KT KK YO. Performed the experiments: CK KT KS YM SF NS SY KK. Analyzed the data: CK KT. Wrote the paper: CK KT YO.","The authors of this manuscript have the following competing interests: CK reports non-financial support from Astellas Pharma Inc., grants from Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, during the conduct of the study. KT reports non-financial support from Astellas Pharma Inc., grants from Ministry of Education, Culture, Sports, Science and Technology of Japan, during the conduct of the study; grants from Astellas Pharma Inc., grants from Novartis Pharma K.K., grants from Daiichi Sankyo Company Limited., grants and personal fees from AstraZeneca K.K., grants and personal fees from Nippon Boehringer Ingelheim Co., Ltd., grants and personal fees from MSD K.K., grants and personal fees from Takeda Pharmaceutical Compamy Limited., personal fees from Kissei Pharmaceutical Co., Ltd., grants from Sanofi K.K., personal fees from Novo Nordisk Pharma Ltd., grants and personal fees from Lilly Japan K.K., personal fees from Ono Pharmaceutical Co., Ltd., grants from Mochida Pharmaceutical Co., LTD., grants from Terumo Co., Ltd., outside the submitted work. KS reports non-financial support from Astellas Pharma Inc., grants from Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, during the conduct of the study. YM reports non-financial support from Astellas Pharma Inc., grants from Ministry of Education, Culture, Sports, Science and Technology of Japan, during the conduct of the study. SF reports non-financial support from Astellas Pharma Inc., grants from Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, during the conduct of the study. NS reports non-financial support from Astellas Pharma Inc., grants from Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, during the conduct of the study. SY reports non-financial support from Astellas Pharma Inc., grants from Ministry of Education, Culture, Sports, Science and Technology of Japan, during the conduct of the study. KK reports other from Astellas Pharma Inc., during the conduct of the study; personal fees from Astellas Pharma Inc., personal fees from Johnson & Johnson K.K., personal fees from Novartis Pharma K.K., personal fees from Kowa Pharmaceutical Company LTD., personal fees from Kyowa Hakko Kirin Co., Ltd., personal fees from Daiichi Sankyo Company Limited., personal fees from AstraZeneca K.K., personal fees from Taisho Toyama Pharmaceutical Co., Ltd., personal fees from Nippon Boehringer Ingelheim Co., Ltd., personal fees from MSD K.K., personal fees from Takeda Pharmaceutical Compamy Limited., personal fees from Kissei Pharmaceutical Co., Ltd., personal fees from Sanofi K.K., personal fees from Novo Nordisk Pharma Ltd., personal fees from Lilly Japan K.K., personal fees from Mitsubishi Tanabe Pharma Corporation, personal fees from Shionogi & Co., Ltd, personal fees from Ono Pharmaceutical Co., Ltd., outside the submitted work. YO reports non-financial support from Astellas Pharma Inc., grants from Ministry of Education, Culture, Sports, Science and Technology of Japan, during the conduct of the study; grants from Astellas Pharma Inc., grants from Novartis Pharma K.K., grants from AstraZeneca K.K., grants from Nippon Boehringer Ingelheim Co., Ltd., grants from MSD K.K., grants from Takeda Pharmaceutical Compamy Limited., grants from Kissei Pharmaceutical Co., Ltd., grants from Sanofi K.K., grants from Lilly Japan K.K., grants from Ono Pharmaceutical Co., Ltd., grants from Mochida Pharmaceutical Co., Ltd., grants from TERUMO CORPORATION, grants from JCR Pharmaceuticals Co., Ltd, grants from ASKA Pharmaceutical Co., Ltd., grants from Eisai Co., Ltd., grants from NIPRO Co., Ltd., grants from Nestle Japan Limited, grants from Pfizer Japan Inc., grants from Shionogi & Co., Ltd., grants from THERAVALUES CORPORATION, grants from Kyowa Hakko Kirin Co,. Ltd., grants from Kowa Pharmaceutical Co., Ltd., grants from Taisho Toyama Pharmaceutical Co., Ltd., grants from TEIJIN PHARMA LIMITED, grants from Mitsubishi Tanabe Pharma Corporation, outside the submitted work. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","03","Chikara Komiya","CK",9,TRUE,4,8,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
